Profiel
Ola Melin is currently the Chief Operating Officer at Circio Holding ASA. Prior to this role, she worked as the Director of Technical Operations at OxThera AB and as the Director of Extended Manufacturing at Swedish Orphan Biovitrum AB. Ms. Melin completed her undergraduate degree at Mälardalen University.
Actieve functies van Ola Melin
| Bedrijven | Functie | Begin |
|---|---|---|
| CIRCIO HOLDING ASA | Operationeel Directeur | - |
Eerdere bekende functies van Ola Melin
| Bedrijven | Functie | Einde |
|---|---|---|
OxThera AB
OxThera AB Medical/Nursing ServicesHealth Services Develops novel treatments for hyperoxaluria leading to kidney damage and potential organ failure | Hoofd Techniek/Wetenschap/O&O | - |
| SWEDISH ORPHAN BIOVITRUM AB | Corporate Officer/Principal | - |
Opleiding van Ola Melin
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 4 |
|---|---|
OxThera AB
OxThera AB Medical/Nursing ServicesHealth Services Develops novel treatments for hyperoxaluria leading to kidney damage and potential organ failure | Health Services |
Mälardalen University
Mälardalen University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Swedish Orphan Biovitrum AB
Swedish Orphan Biovitrum AB Pharmaceuticals: MajorHealth Technology Manufactures and supplies pharmaceuticals and orphan drugs in the areas of hematology, immunology and specialty care | Health Technology |
Circio Holding ASA
Circio Holding ASA BiotechnologyHealth Technology Develops active immunotherapy cancer vaccines | Health Technology |
















